SuperworthEstrella Immunopharma shares outstanding ESLA
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 43M
- On a year earlier
- +18.9%
- more shares
Estrella Immunopharma had 43M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 18.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 37.8M | +4% |
| FY2024 | 36.4M | −1% |
| FY2024 | 36.8M | +21720% |
| FY2022 | 168.8K | −88% |
| FY2021 | 1.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 43M | +19% | |
| Q1 FY26 | 42.1M | +16% | |
| Q4 FY25 | 37.8M | +4% | |
| Q3 FY25 | 37.1M | +4% | |
| Q2 FY25 | 36.2M | +3% | |
| Q1 FY25 | 36.2M | +3338% | |
| Q4 FY24 | 36.8M | +5% | |
| Q2 FY24 | 36.2M | +5989% | |
| Q4 FY24 | 36.4M | +6018% | |
| Q3 FY24 | 35.5M | +10431% | |
| Q2 FY24 | 35.2M | +5820% | |
| Q1 FY24 | 1.1M | +212% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Estrella Immunopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.